IP Library Granted Patent US 12,472,313
Granted Patent B2
US 12,472,313 · App. 17/856,498 · Granted Nov 18, 2025

Apparatuses and methods for delivering powdered agents

Inventors: Amanda Lynn Smith (Brookline, MA); Gerald Fredrickson (Westford, MA); Dennis Brian Hubbard, Jr. (Lancaster, MA); Stan Robert Gilbert (Litchfield, NH); Caitlyn Emily Bintz (Marlborough, MA); Andrew Pic (Ashland, MA)
Assignee: Boston Scientific Scimed, Inc.
A61M11/02A61M13/00A61B2017/00893A61M11/06A61M15/0005A61M15/0008A61M15/0065A61M16/127A61M2202/064A61M2205/8218
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,472,313
App. No.
17/856,498
Granted
Nov 18, 2025
Kind
B2
Abstract

In one aspect of the present disclosure, an apparatus for delivering a powdered agent into a subject's body may include a powder chamber housing the powdered agent. The apparatus also may include a chassis in fluid connection with the powder chamber. The chassis may include a first passage for receiving a pressurized gas, a second passage for receiving the powdered agent from the powder chamber, and a junction in fluid communication with the first passage and the second passage. At least a first portion of the pressurized gas is introduced into the powdered agent at the junction to fluidize the powdered agent.

Claims (49)

1 . An apparatus, comprising:

a powder chamber housing a powdered agent; and

a chassis in fluid communication with the powder chamber, the chassis including:

a first passage for receiving a pressurized fluid;

a second passage configured to receive the powdered agent from the powder chamber;

a tapered region positioned downstream from the second passage, wherein at least a portion of the powdered agent from the powder chamber is received in the tapered region; and

a third passage in fluid communication with the first passage and the second passage via the tapered region, the third passage is configured to direct the pressurized fluid from the first passage to the tapered region, wherein the third passage includes a longitudinal axis that extends relatively upward and laterally away from the first passage, such that an angle of the third passage relative to the tapered region causes the pressurized fluid to be emitted tangentially relative to a wall of the tapered region to create a vortex of the pressurized fluid and the powdered agent within the second passage;

wherein the chassis is configured to:

(i) direct the portion of the powdered agent received in the tapered region upstream into the second passage and toward the powder chamber in response to receiving the pressurized fluid;

(ii) agitate the powdered agent; and

(iii) direct the agitated powdered agent downstream from the second passage through the tapered region to exit the chassis.

2 . The apparatus of claim 1 , further including an agitation mechanism at least partially disposed within the powder chamber, and configured to agitate the powdered agent housed within the powder chamber to inhibit clogging of the powdered agent within the powder chamber.

3 . The apparatus of claim 2 , wherein the agitation mechanism includes a central shaft and one or more flanges extending laterally outward from the central shaft.

4 . The apparatus of claim 3 , wherein the agitation mechanism is configured to move relative to the powder chamber in response to the chassis directing the portion of the powdered agent positioned in the tapered region upstream toward the powder chamber.

5 . The apparatus of claim 3 , further including an actuator coupled to the agitation mechanism, wherein the agitation mechanism is configured to move relative to the powder chamber in response to an actuation of the actuator.

6 . The apparatus of claim 1 , wherein the powder chamber is positioned upstream from the chassis, such that the powdered agent moves downstream from the powder chamber into the second passage via gravity.

7 . The apparatus of claim 1 , wherein the wall of the tapered region includes an opening positioned adjacent to an outlet end of the third passage; and

wherein the outlet end of the third passage extends through the opening such that the outlet end is suspended inside the tapered region.

8 . The apparatus of claim 1 , wherein the second passage includes a first non-tapered region positioned upstream from the tapered region such that the first non-tapered region is positioned between the powder chamber and the tapered region.

9 . The apparatus of claim 8 , wherein the second passage includes a second non-tapered region positioned downstream from the tapered region such that the tapered region is positioned between the first non-tapered region and the second non-tapered region.

10 . The apparatus of claim 9 , wherein the first non-tapered region has a first width that is constant along a length of the first non-tapered region, the second non-tapered region has a second width that is smaller than the first width and constant along a length of the second non-tapered region.

11 . The apparatus of claim 10 , wherein the tapered region has a third width that varies along a length of the tapered region, and is greater along a first portion adjacent to the first non-tapered region than along a second portion adjacent to the second non-tapered region.

12 . The apparatus of claim 1 , wherein the tapered region defines a funnel that is configured to facilitate outflow of the powdered agent from the second passage out of the chassis and inhibit clogging or packing of the powdered agent within the second passage.

13 . An apparatus, comprising:

a powder chamber storing a powdered agent; and

a chassis in fluid communication with the powder chamber, the chassis including:

a first passage for receiving a pressurized fluid;

a second passage configured to receive the powdered agent from the powder chamber;

a tapered region positioned downstream from the second passage for receiving at least a portion of the powdered agent from the powder chamber; and

a third passage in fluid communication with the first passage and the tapered region, such that the third passage is configured to direct the pressurized fluid from the first passage to the tapered region, wherein the third passage includes a longitudinal axis that extends relatively upward and laterally away from the first passage, to cause the pressurized fluid to be emitted tangentially relative to a wall of the tapered region to create a vortex of the pressurized fluid and the powdered agent in the second passage;

wherein the chassis is configured to (i) direct the portion of the powdered agent received in the tapered region upstream into the second passage and toward the powder chamber, (ii) agitate the powdered agent, and (iii) direct the agitated powdered agent downstream from the second passage through the tapered region for exiting the chassis.

14 . The apparatus of claim 13 , further including an agitation mechanism at least partially disposed within the powder chamber, and configured to agitate the powdered agent stored within the powder chamber to inhibit packing of the powdered agent within the powder chamber.

15 . The apparatus of claim 14 , wherein the agitation mechanism includes an auger having a central shaft and one or more flanges extending laterally outward from the central shaft.

16 . The apparatus of claim 15 , wherein the agitation mechanism is configured to rotate relative to the powder chamber in response to the chassis directing the portion of the powdered agent positioned in the tapered region upstream toward the powder chamber.

17 . The apparatus of claim 13 , wherein the second passage includes a first non-tapered region and a second non-tapered region, wherein the tapered region is positioned between the first non-tapered region and the second non-tapered region.

18 . The apparatus of claim 13 , wherein the wall of the tapered region includes at least one opening facing the third passage such that the third passage is in fluid communication with the tapered region via the at least one opening; and

wherein the third passage extends through the at least one opening such that the third passage is positioned proximate to a central longitudinal axis of the tapered region.

19 . The apparatus of claim 13 , wherein the tapered region defines a funnel that is configured to direct the powdered agent out of the second passage and inhibit the powdered agent from clogging the second passage.

20 . An apparatus, comprising:

a powder chamber housing a powdered agent; and

a chassis in fluid communication with the powder chamber, the chassis including:

a first passage for receiving pressurized fluid;

a second passage configured to receive the powdered agent from the powder chamber;

a tapered region positioned downstream from the second passage for receiving a portion of the powdered agent from the powder chamber; and

a third passage for directing the pressurized fluid from the first passage into the second passage via the tapered region, wherein the third passage extends longitudinally upward and laterally away from the first passage, such that the pressurized fluid is emitted tangentially relative to a wall of the tapered region and creates a vortex of the pressurized fluid and the powdered agent in the second passage;

wherein the chassis is configured to:

(i) move the portion of the powdered agent received in the tapered region upstream into the second passage;

(ii) agitate the powdered agent within the second passage; and

(iii) direct the agitated powdered agent downstream from the second passage through the tapered region and out of the second passage.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2022
From: SMITH, AMANDA LYNN; FREDRICKSON, GERALD; HUBBARD, DENNIS BRIAN, JR; GILBERT, STAN ROBERT; BINTZ, CAITLYN EMILY; PIC, ANDREW
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 060395/0380 →
Continuity (3)
Continuation 15865723 · Jan 9, 2018
Provisional Application 62444586 · Jan 10, 2017
Related Publication 20220331528A1 · Oct 20, 2022
References Cited (213)
US 471854A · Howard · 1892 [cited by applicant]
US 881238A · Hasbrouck · 1908 [cited by applicant]
US 1145520A · Smith · 1915 [cited by applicant]
US 1599959A · Buheiji · 1926 [cited by applicant]
US 1732566A · McKendrick · 1929 [cited by applicant]
US 2151418A · Brown · 1939 [cited by applicant]
US 2185927A · Shelanski · 1940 [cited by applicant]
US 2478715A · Schmitt · 1949 [cited by applicant]
US 2623519A · Cohen · 1952 [cited by applicant]
US 2884231A · Pyle · 1959 [cited by examiner]
US 3044908A · Baldi · 1962 [cited by applicant]
US 3237805A · Stogner · 1966 [cited by applicant]
US 3425600A · Abplanalp · 1969 [cited by applicant]
US 3485535A · Fabre · 1969 [cited by applicant]
US 3669113A · Altounyan et al. · 1972 [cited by applicant]
US 3940061A · Gimple et al. · 1976 [cited by applicant]
US 4184258A · Barrington et al. · 1980 [cited by applicant]
US 4427450A · Kostansek · 1984 [cited by applicant]
US 4457329A · Werley et al. · 1984 [cited by applicant]
US 4620847A · Shishov et al. · 1986 [cited by applicant]
US 4678377A · Bouchard · 1987 [cited by applicant]
US 4806167A · Raythatha · 1989 [cited by applicant]
US 4824295A · Sharpless · 1989 [cited by applicant]
US 5215221A · Dirksing · 1993 [cited by applicant]
US 5231983A · Matson et al. · 1993 [cited by applicant]
US 5273531A · Knoepfler · 1993 [cited by applicant]
US 5310407A · Casale · 1994 [cited by applicant]
US 5312331A · Knoepfler · 1994 [cited by applicant]
US 5312333A · Churinetz et al. · 1994 [cited by applicant]
US 5366122A · Guentert et al. · 1994 [cited by applicant]
US 5445612A · Terakura et al. · 1995 [cited by applicant]
US 5470311A · Setterstrom et al. · 1995 [cited by applicant]
US 5618177A · Abbott · 1997 [cited by applicant]
US 5884621A · Matsugi et al. · 1999 [cited by applicant]
US 5951531A · Ferdman et al. · 1999 [cited by applicant]
US 6003512A · Gerde · 1999 [cited by applicant]
US 6261258B1 · Saines · 2001 [cited by applicant]
US 6484750B1 · Foos et al. · 2002 [cited by applicant]
US 6554022B2 · Wakeman · 2003 [cited by applicant]
US 6589087B2 · Mackal et al. · 2003 [cited by applicant]
US 6684917B2 · Zhu et al. · 2004 [cited by applicant]
US 6708712B2 · Wakeman · 2004 [cited by applicant]
US 6716190B1 · Glines et al. · 2004 [cited by applicant]
US 6722363B1 · Von Schuckmann · 2004 [cited by applicant]
US 6799571B1 · Hughes et al. · 2004 [cited by applicant]
US 6945953B2 · Wright · 2005 [cited by applicant]
US 7178547B2 · Mackal · 2007 [cited by applicant]
US 7311270B2 · Kapila · 2007 [cited by applicant]
US 7334598B1 · Hollars · 2008 [cited by applicant]
US 7361300B2 · Kelly et al. · 2008 [cited by applicant]
US 7427607B2 · Suzuki · 2008 [cited by applicant]
US 7455248B2 · Kablik et al. · 2008 [cited by applicant]
US 7461649B2 · Gamard et al. · 2008 [cited by applicant]
US 7465287B2 · James · 2008 [cited by applicant]
US 7544177B2 · Gertner · 2009 [cited by applicant]
US 7563299B2 · Costa et al. · 2009 [cited by applicant]
US 7673647B2 · Mackal · 2010 [cited by applicant]
US 7841338B2 · Dunne et al. · 2010 [cited by applicant]
US 7892205B2 · Palasis et al. · 2011 [cited by applicant]
US 7921874B2 · Tekulve et al. · 2011 [cited by applicant]
US 8037880B2 · Zhu et al. · 2011 [cited by applicant]
US 8097071B2 · Burgess et al. · 2012 [cited by applicant]
US 8118777B2 · Ducharme et al. · 2012 [cited by applicant]
US 8269058B2 · McCarthy et al. · 2012 [cited by applicant]
US 8313474B2 · Campbell et al. · 2012 [cited by applicant]
US 8360276B2 · Rogier et al. · 2013 [cited by applicant]
US 8361054B2 · Ducharme et al. · 2013 [cited by applicant]
US 8496189B2 · Lomond et al. · 2013 [cited by applicant]
US 8673065B2 · Burgess et al. · 2014 [cited by applicant]
US 8721582B2 · Ji · 2014 [cited by applicant]
US 8728032B2 · Ducharme et al. · 2014 [cited by applicant]
US 8741335B2 · McCarthy · 2014 [cited by applicant]
US 8827980B2 · Ji · 2014 [cited by applicant]
US 8834411B2 · Shay et al. · 2014 [cited by applicant]
US 8910627B2 · Iwatschenko et al. · 2014 [cited by applicant]
US 8951565B2 · McCarthy · 2015 [cited by applicant]
US 9028437B2 · Ott et al. · 2015 [cited by applicant]
US 9089658B2 · Dunne et al. · 2015 [cited by applicant]
US 9101744B2 · Ducharme · 2015 [cited by applicant]
US 9107668B2 · Melsheimer et al. · 2015 [cited by applicant]
US 9132206B2 · McCarthy · 2015 [cited by applicant]
US 9204957B2 · Gregory et al. · 2015 [cited by applicant]
US 9205170B2 · Lucchesi et al. · 2015 [cited by applicant]
US 9205207B2 · Ji · 2015 [cited by applicant]
US 9205240B2 · Greenhalgh et al. · 2015 [cited by applicant]
US 9308584B2 · Burgess et al. · 2016 [cited by applicant]
US 9310812B2 · Costle et al. · 2016 [cited by applicant]
US 9375533B2 · Ducharme et al. · 2016 [cited by applicant]
US 9492646B2 · Hoogenakker et al. · 2016 [cited by applicant]
US 9517976B2 · Mackal · 2016 [cited by applicant]
US 9545490B2 · Iwatschenko et al. · 2017 [cited by applicant]
US 9555185B2 · Foster et al. · 2017 [cited by applicant]
US 9629966B2 · Ji · 2017 [cited by applicant]
US 9636470B2 · Pohlmann et al. · 2017 [cited by applicant]
US 9707359B2 · Kubo · 2017 [cited by applicant]
US 9713682B2 · Eistetter et al. · 2017 [cited by applicant]
US 9717897B2 · Rogier · 2017 [cited by applicant]
US 9821084B2 · Diegelmann et al. · 2017 [cited by applicant]
US 9839772B2 · Ducharme · 2017 [cited by applicant]
US 9839774B2 · Bonaldo · 2017 [cited by applicant]
US 9846439B2 · Carman et al. · 2017 [cited by applicant]
US 9867931B2 · Gittard · 2018 [cited by applicant]
US 9976660B2 · Stanton et al. · 2018 [cited by applicant]
US 10004690B2 · Lee et al. · 2018 [cited by applicant]
US 10010705B2 · Greenhalgh et al. · 2018 [cited by applicant]
US 10017231B2 · Fawcett, Jr. · 2018 [cited by applicant]
US 10036617B2 · Mackal · 2018 [cited by applicant]
US 10065004B2 · Eder et al. · 2018 [cited by applicant]
US 10173019B2 · Kaufmann et al. · 2019 [cited by applicant]
US 10384049B2 · Stanton et al. · 2019 [cited by applicant]
US 10463811B2 · Lee et al. · 2019 [cited by applicant]
US 10507293B2 · Goodman et al. · 2019 [cited by applicant]
US 10646706B2 · Rogier · 2020 [cited by applicant]
US 10730595B2 · Fawcett · 2020 [cited by applicant]
US 10751523B2 · Rogier · 2020 [cited by applicant]
US 10806853B2 · Gittard · 2020 [cited by applicant]
US 10850814B2 · Fawcett · 2020 [cited by applicant]
US 10994818B2 · Hernandez · 2021 [cited by applicant]
US 11406771B2 · Smith · 2022 [cited by examiner]
US 20020088463A1 · Keane et al. · 2002 [cited by applicant]
US 20040107963A1 · Finlay et al. · 2004 [cited by applicant]
US 20040249359A1 · Palasis et al. · 2004 [cited by applicant]
US 20050121025A1 · Gamard et al. · 2005 [cited by applicant]
US 20050147656A1 · McCarthy et al. · 2005 [cited by applicant]
US 20050205087A1 · Kablik et al. · 2005 [cited by applicant]
US 20050220721A1 · Kablik et al. · 2005 [cited by applicant]
US 20060004314A1 · McCarthy et al. · 2006 [cited by applicant]
US 20060213514A1 · Price et al. · 2006 [cited by applicant]
US 20070056586A1 · Price et al. · 2007 [cited by applicant]
US 20070066920A1 · Hopman et al. · 2007 [cited by applicant]
US 20070066924A1 · Hopman et al. · 2007 [cited by applicant]
US 20070082023A1 · Hopman et al. · 2007 [cited by applicant]
US 20070083137A1 · Hopman et al. · 2007 [cited by applicant]
US 20070125375A1 · Finlay · 2007 [cited by examiner]
US 20070151560A1 · Price et al. · 2007 [cited by applicant]
US 20070160543A1 · Moller · 2007 [cited by applicant]
US 20070199824A1 · Hoerr et al. · 2007 [cited by applicant]
US 20080021374A1 · Kawata · 2008 [cited by applicant]
US 20080287907A1 · Gregory et al. · 2008 [cited by applicant]
US 20090013994A1 · Jones et al. · 2009 [cited by applicant]
US 20090101144A1 · Gamard et al. · 2009 [cited by applicant]
US 20090155342A1 · Diegelmann et al. · 2009 [cited by applicant]
US 20090214992A1 · McKnight · 2009 [cited by examiner]
US 20090281486A1 · Ducharme · 2009 [cited by applicant]
US 20100121261A1 · Kablik et al. · 2010 [cited by applicant]
US 20100305505A1 · Ducharme et al. · 2010 [cited by applicant]
US 20110073200A1 · Overvaag et al. · 2011 [cited by applicant]
US 20110274726A1 · Guo et al. · 2011 [cited by applicant]
US 20110308516A1 · Price et al. · 2011 [cited by applicant]
US 20130218072A1 · Kubo · 2013 [cited by examiner]
US 20140018729A1 · Foster et al. · 2014 [cited by applicant]
US 20140271491A1 · Gittard et al. · 2014 [cited by applicant]
US 20150094649A1 · Gittard · 2015 [cited by applicant]
US 20150125513A1 · McCarthy · 2015 [cited by applicant]
US 20160375202A1 · Goodman et al. · 2016 [cited by applicant]
US 20170106181A1 · Bonaldo et al. · 2017 [cited by applicant]
US 20170232141A1 · Surti et al. · 2017 [cited by applicant]
US 20170252479A1 · Ji et al. · 2017 [cited by applicant]
US 20170296760A1 · Lee · 2017 [cited by examiner]
US 20180099088A1 · Gittard · 2018 [cited by applicant]
US 20180193574A1 · Smith et al. · 2018 [cited by applicant]
US 20180214160A1 · Hoskins et al. · 2018 [cited by applicant]
US 20180339144A1 · Greenhalgh et al. · 2018 [cited by applicant]
US 20190134366A1 · Erez et al. · 2019 [cited by applicant]
US 20190217315A1 · Maguire et al. · 2019 [cited by applicant]
US 20190232030A1 · Pic et al. · 2019 [cited by applicant]
US 20210024187A1 · Fawcett et al. · 2021 [cited by applicant]
US 20210069485A1 · Rogier · 2021 [cited by applicant]
US 20220331528A1 · Smith et al. · 2022 [cited by applicant]
CN 1720072A · 2006 [cited by applicant]
CN 101730797A · 2010 [cited by applicant]
CN 101401956B · 2012 [cited by applicant]
CN 106075678A · 2016 [cited by applicant]
DE 60215438 · 2007 [cited by applicant]
EP 2689796A1 · 2014 [cited by applicant]
EP 3052168B1 · 2019 [cited by applicant]
JP H6285400A · 1994 [cited by applicant]
JP H07118305A · 1995 [cited by applicant]
JP 2001315961A · 2001 [cited by applicant]
JP 200278774A · 2002 [cited by applicant]
JP 2006507876A · 2006 [cited by applicant]
JP 201119970A · 2011 [cited by applicant]
JP 201162545A · 2011 [cited by applicant]
JP 2012143502A · 2012 [cited by applicant]
JP 2012152420A · 2012 [cited by applicant]
WO 03013552A1 · 2003 [cited by applicant]
WO 2004066806A2 · 2004 [cited by applicant]
WO 2005062896A2 · 2005 [cited by applicant]
WO 2006071649A2 · 2006 [cited by applicant]
WO 2006088912A2 · 2006 [cited by applicant]
WO 2008033462A2 · 2008 [cited by applicant]
WO 2009061409A1 · 2009 [cited by applicant]
WO 2015050814A2 · 2015 [cited by applicant]
WO 2016048006A1 · 2016 [cited by applicant]
WO 2018157772A1 · 2018 [cited by applicant]
Japanese Office Action in Japanese Application No. 2022-129455, dated Aug. 1, 2023 (14 pages). [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v1”, Cook Medical, 2012. [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v2”, Cook Medical, 2013. [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v3”, Cook Medical, 2014. [cited by applicant]
Arefnia, Ali, et al. “Comparative Study on the Effect of Tire-Derived Aggregate on Specific Gravity of Kaolin.” Electronic Journal of Geotechnical Engineering 18 (2013): 335-44. [cited by applicant]
Aslanian, Harry R., and Loren Laine. “Hemostatic powder spray for GI bleeding.” Gastrointestinal endoscopy 77.3 (2013): 508-510. [cited by applicant]
Bridevaux, Pierre-Olivier, et al. “Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study.” European Respiratory Journal 38.4 (2011):… [cited by applicant]
Cook Medical. Hemospray Endoscopic Hemostat, Cook, 2014. (7 pages, in English). [cited by applicant]
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296… [cited by applicant]
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296… [cited by applicant]
Giday, Samuel A., et al. “A long-term randomized controlled trial of a novel nanopowder hemostatic agent for control of severe upper gastrointestinal bleeding in a porcine model.” Gastrointestinal Endoscopy 69.5 (2009):… [cited by applicant]
Giday, Samuel, et al. “Safety analysis of a hemostatic powder in a porcine model of acute severe gastric bleeding.” Digestive diseases and sciences 58.12 (2013): 3422-3428. [cited by applicant]
Japanese Office Action dated Jan. 11, 2022 in counterpart Japanese Patent Application 2019-536821 (5 pages, in Japanese). [cited by applicant]
Kesavan, Jana, et al. “Density Measurements of Materials Used in Aerosol Studies”. Edgewood Chemical Biological Center Aberdeen Proving Ground MD, 2000. [cited by applicant]
Micromeritics. “Application Note: Bulk and Skeletal Density Computations for the AutoPore.” May 2012. (3 pages, in English). [cited by applicant]
Micromeritics. Density Analysis, 2001. (6 pages, in English). [cited by applicant]
Regalia, Kristen, et al. “Hemospray in Gastrointestinal Bleeding.” Practical Gastroenterology. Endoscopy: Opening New Eyes, ser. 8, May 2014, pp. 13-24. 8. [cited by applicant]
Retsch GmbH Haan. Sieve Analysis: Taking a Close Look at Quality, An Expert Guide to Particle Size Analysis. 2015. (56 pages, in English). [cited by applicant]